Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaine–epinephrine combination

Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaine–epinephrine combination

Accepted Manuscript Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaineepinephrine combination Patricia C. Duarte, Cahuê FR...

1MB Sizes 0 Downloads 48 Views

Accepted Manuscript Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaineepinephrine combination Patricia C. Duarte, Cahuê FR. Paz, Alvaro PL. Oliveira, Thairê P. Maróstica, Leticia O. Cota, Rafael R. Faleiros PII:

S1467-2987(17)30055-7

DOI:

10.1016/j.vaa.2016.11.003

Reference:

VAA 81

To appear in:

Veterinary Anaesthesia and Analgesia

Received Date: 17 August 2016 Revised Date:

2 November 2016

Accepted Date: 4 November 2016

Please cite this article as: Duarte PC, Paz CF, Oliveira AP, Maróstica TP, Cota LO, Faleiros RR, Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaine-epinephrine combination, Veterinary Anaesthesia and Analgesia (2017), doi: 10.1016/j.vaa.2016.11.003. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT RESEARCH PAPER

2

PC Duarte et al.

3

Lidocaine-bicarbonate equine epidural block

4

Caudal epidural anesthesia in mares after bicarbonate addition to a lidocaine-

5

epinephrine combination

6

Patricia C Duarte, Cahuê FR Paz, Alvaro PL Oliveira, Thairê P Maróstica, Leticia O Cota &

7

Rafael R Faleiros

8

Department of Veterinary Clinics and Surgery, Universidade Federal de Minas Gerais, Belo

9

Horizonte, Brazil

10

M AN U

SC

RI PT

1

Correspondence: Rafael R Faleiros, Escola de Veterinária da Universidade Federal de

12

Minas Gerais, Departamento de Clínica e Cirurgia Veterinárias, Av. Antônio Carlos 6627,

13

caixa postal 567, Campus Pampulha da UFMG, Belo Horizonte, Minas Gerais, Brasil, 31270-

14

901. E-mail: [email protected]

15 16

TE D

11

Abstract

18

Objective To investigate the nociceptive and clinical effects of buffering a lidocaine-

19

epinephrine solution with sodium bicarbonate in caudal epidural block in mares.

20

Study design Prospective randomized controlled trial.

21

Animals Six mixed-breed mares weighing 350–440 kg.

22

Methods Each animal was administered two caudal epidural injections, 72 hours apart, using

23

different solutions prepared immediately before injection. The control solution was 7 mL 2%

24

lidocaine hydrochloride with epinephrine hemitartrate (1:200 000) added to 3 mL sterile

AC C

EP

17

1

ACCEPTED MANUSCRIPT water for injection (pH 2.9). The alkalinized solution was 7 mL of lidocaine-epinephrine

26

solution added to 2.3 mL sterile water for injection and 0.7 mL 8.4% sodium bicarbonate (pH

27

7.4). Nociception was evaluated by response to skin pinching at 31 sites in the sacral region

28

and around the perimeter of the anogenital area (distances of 10, 15, and 20 cm) before and 5,

29

10 and 15 minutes after epidural injection, then every 15 minutes until the return of

30

nociception in all evaluated sites. The onset and duration times, and intensity of ataxia

31

(grades 0 to 3) were recorded. The paired t test was used to compare the onset and duration of

32

anesthesia and ataxia (p < 0.05).

33

Results Alkalization of the solution resulted in significant decreases in the average time of

34

onset of loss of nociception in the sacral region (40%) and around the perimeter of the

35

anogenital area extending up to 5 cm (36%) and from 5 to 10 cm (32%) from the anus and

36

vulva. Alkalization also decreased the average duration of ataxia (33%), without affecting the

37

duration and extent of anesthesia or the degree of ataxia.

38

Conclusions and clinical relevance Alkalization of lidocaine-epinephrine solution is

39

advantageous in shortening the duration of ataxia and hastening the onset of anesthesia in

40

areas adjacent to the anogenital area, without reducing the duration of epidural anesthesia, in

41

mares.

43 44

SC

M AN U

TE D

EP

AC C

42

RI PT

25

Keywords epinephrine, equine, local anesthetic, nociception, sodium bicarbonate.

2

ACCEPTED MANUSCRIPT Introduction

46

Lidocaine is a local anesthetic with rapid onset and moderate duration of activity and

47

moderate toxicity, and is therefore the most widely used agent for local anesthesia in

48

veterinary medicine (Garcia 2015). Although concerns exist about the risk of ischemia and

49

tissue necrosis when vasoconstrictors are added to the epidural solution (Moyer et al. 2011;

50

Garcia 2015), epinephrine may increase duration of equine epidural anesthesia when added to

51

lidocaine (Carpenter & Byron 2015; Garcia 2015).

52

Epidural anesthesia can be performed in the standing horse, avoiding the risks of decubitus

53

and arising from general anesthesia (Robinson & Natalini 2002; Garcia 2015). However, the

54

onset of epidural anesthesia with lidocaine can be particularly long in horses compared with

55

other domestic species (Hall et al. 2001; Garcia 2015). This may lead to the false conception

56

that the epidural space was not reached (Hall et al 2001) or a long onset time may be a

57

problem in patient management, especially for a restless horse requiring physical restraint

58

and sedation and in emergency situations.

59

Commercially available local anesthetic with vasoconstrictor solutions are formulated to be

60

acidic to avoid oxidation of epinephrine and increase shelf life (Moore 1981; Lambert 2002;

61

Garcia 2015). This low pH results in predominance of the ionized hydrophilic form,

62

diminishing diffusion of the anesthetic through cell membranes and delaying its arrival at the

63

site of action (Garcia 2015). The medical and veterinary literature reports quicker onset of

64

anesthesia (DiFazio et al. 1986; Fernando & Jones 1991; Patel et al. 1996) and reduced pain

65

on injection (McKay et al. 1987; Eccarius et al. 1990) when sodium bicarbonate is added to a

66

local anesthetic thereby increasing the pH to a physiologic value.

67

This study aimed to evaluate and compare the onset, duration and sites anesthetized in the

68

anogenital region, and some clinical effects, with caudal epidural anesthesia in horses

AC C

EP

TE D

M AN U

SC

RI PT

45

3

ACCEPTED MANUSCRIPT 69

performed using lidocaine with epinephrine, with and without sodium bicarbonate added as

70

an alkalizing agent. The hypothesis was that adjusting the pH of the epidural injectate to

71

within the physiological range before administration can reduce the anesthesia latency time.

72

Materials and methods

74

Animals

75

The study was approved by the Ethics Committee on Animal Use of the Universidade Federal

76

de Minas Gerais, Brazil (no. 200/2013). Six mixed-breed mares were selected from a group

77

of 8 horses. They were aged [mean ± standard deviation (SD)] 12.8 ± 2.8 years (range: 8–16

78

years), with body condition score of 6.5 ± 1 (range: 5–8) out of 9, and weight of 397 ± 40 kg

79

(range: 350–440 kg). All six mares were considered physically healthy on clinical

80

examination and had been proved to have a predictable anesthetic response to caudal epidural

81

injection of lidocaine 2% using the technique described below. The mares were kept in a

82

group paddock, where they were fed with Tifton hay and had access to water ad libitum.

83

TE D

M AN U

SC

RI PT

73

Anesthetic solutions

85

Each animal was administered two treatments at an interval of at least 72 hours. The order of

86

treatments was randomized (toss of a coin) for each mare without the knowledge of the

87

evaluator, in a crossover design. The control solution (treatment CON) was 7 mL lidocaine

88

hydrochloride

89

Pharmaceuticals Ltd., Brazil) and 3 mL sterile water for injection (Equiplex Pharmaceutical

90

Industry, Brazil). The alkalinized solution (treatment ALC) was 7 mL lidocaine

91

hydrochloride with epinephrine hemitartrate 1:200 000, 0.7 mL sodium bicarbonate (8.4%

92

sodium bicarbonate; Samtec Biotechnology, Brazil) and 2.3 mL sterile water for injection

AC C

EP

84

with

epinephrine

hemitartrate

1:200 000

(Xylestesin

2%;

Cristália

4

ACCEPTED MANUSCRIPT 93

(equivalent to 0.005 mEq bicarbonate per mg of lidocaine). The solutions were prepared by

94

an assistant at the time of epidural administration. The pH and density of both solutions were

95

measured with a pH meter (mPA210; MS Tecnopon Instrumentation, Brazil) and a

96

refractometer (RHC-200ATC; Megabrix, Brazil), respectively.

RI PT

97

Assessments

99

The sites to be tested were demarcated on the horse (Fig.1). Four concentric ellipses were

100

drawn 5, 10, 15, and 20 cm outside the virtual ellipse delimited by anus and vulva. In

101

addition, two lines were drawn parallel to the ground, the first at the level of the anal

102

sphincter and the second at the ventral vulvar commissure, and two lines were drawn parallel

103

to the longitudinal axis of the sacral vertebrae at the level of the lateral borders of the tail.

104

The test sites were located at the centers of the delimited areas on both antimeres and the

105

sacrum, and at the anal sphincter, perineum, dorsal and ventral vulvar commissures. For

106

analysis purposes, the test sites were grouped in six concentric anatomic regions as follows:

107

the anogenital (AG) region, sacral (SC) region, and perianogenital regions corresponding to

108

the ellipses 5, 10, 15, and 20 cm outside the anogenital region (P5-P20). In addition, the sites

109

were grouped on the basis of a dorsal–ventral distribution in anatomic thirds: dorsal (DT),

110

middle (MT) and ventral (VT) (Fig. 1).

111

The nociception was tested with the horse confined in a stocks by using a pinching technique

112

with an Adson thumb forceps, and systematically applying stimulation at the 31 defined sites.

113

Nociception was always assessed by the same evaluator blinded to the treatment. To avoid

114

distractions in the environment on the behavior of the mare, a blindfold was applied over the

115

eyes of each animal during the nociception test. In the week previous to the experimental

116

period, all the horses were acclimatized in the stocks with a blindfold once a day for 3 hours.

AC C

EP

TE D

M AN U

SC

98

5

ACCEPTED MANUSCRIPT Positive reactions to the noxious stimulus were raising and pricking the ears, turning the head

118

towards the croup, tucking the croup, and threatening to kick.

119

Tests for nociception were performed before anesthesia (T0); 5 (T1), 10 (T2), and 15 (T3)

120

minutes after epidural injection; and 15 minutes thereafter until positive reactions to the

121

noxious stimulus were observed in all tested areas. Heart rate (HR), respiratory rate (fR), and

122

rectal temperature (RT) were measured before nociception testing at T0, T3, and T4 and

123

every 30 minutes thereafter. At these same time points, after nociceptive testing, the horse

124

was unmasked and encouraged to walk out of the stocks. Ataxia was scored 0-3: 0, walking

125

and turning firmly; 1, mild ataxia, walking with some limb weakness; 2, moderate ataxia,

126

walking with support, staggering, risk of falling when turned; 3, marked ataxia, inability to

127

walk or exit the stocks without risk of falling, falling when turned (Taylor et al. 2014). Mares

128

were only returned to the group paddock when pain sensation and motor function were

129

considered totally normal.

M AN U

SC

RI PT

117

TE D

130

Epidural technique

132

With the mare restrained in the stocks, the sacrococcygeal region was shaved. The site for

133

needle insertion was identified by moving the tail up and down and palpation of the first

134

articulation caudal to the sacrum. After the shaved area had been prepared according to a

135

surgical antisepsis technique, a 1.7 × 50 mm needle with no stilette (Angiocath, BD Medical,

136

Brazil) was inserted in the center of the palpated depression at a 90° angle to the skin plane.

137

The correct placement of the needle in the epidural space was confirmed using the hanging-

138

drop method and sensing a lack of resistance in the syringe plunger during solution infusion.

139

The same researcher (PD) performed all the epidural injections.

AC C

EP

131

140

6

ACCEPTED MANUSCRIPT Statistical analysis

142

The nociception data were analyzed in two ways. First, the effect of the treatment on the

143

onset and duration of anesthesia was analyzed by comparing the values of each site and the

144

values of each region (the arithmetic mean of all sites in the region) between treatments.

145

Second, the effect of the treatment on the distribution of the anesthetic solution was analyzed

146

in each treatment by comparing the values for the onset and duration of the anesthesia among

147

the dorsal, middle, and ventral thirds and between antimeres. The paired t test was used to

148

compare values between treatments or antimeres. A repeated measures ANOVA was used to

149

compare values among thirds within treatments.

150

The clinical variables (HR, fR and RT) were subjected to a two-way repeated measures

151

ANOVA followed by the Tukey’s post hoc test. Ataxia was compared between treatments by

152

using the Mann–Whitney test for degree data and the paired t test for duration data.

153

For all parametric analyses, normality was assessed using the Shapiro–Wilk test and, if

154

necessary, data were transformed before analysis by using the natural logarithms. Statistical

155

analyses were performed using the SigmaStat 4.0 software (Systat Software, CA, USA) and

156

GraphPad Prism 5.0 (GraphPad Software, CA, USA), and p < 0.05 was considered

157

significant.

EP

AC C

158

TE D

M AN U

SC

RI PT

141

159

Results

160

From an initial group of eight mares, two mares were rejected. The perineum in the first mare

161

could not be anesthetized and in the second, epidural anesthesia always appeared to be

162

unilateral.

163

The pH and density of the epidural solutions were pH 2.98 and 1010 g L-1 in CON and pH

164

7.44 and 1012 g L-1 in ALC. The onset of anesthesia was significantly shorter in ALC than in 7

ACCEPTED MANUSCRIPT CON, by 40% in the SC region, 36% in P5, and 32% in P10 (p = 0.029, p = 0.003 and p =

166

0.005, respectively) (Table 1). There were no significant differences between treatments in

167

the duration of anesthesia, or between the left and right antimeres.

168

Failures of desensitization occurred in both treatments with the sum of 18 unblocked areas

169

within each treatment. In CON, there was one unblocked area in AG, two in P5, four in P15,

170

and 11 in P20. In ALC, there was one unblocked area in P5, three in P15, and 14 in P20.

171

Failures of desensitization occurred predominantly in the ventral areas.

172

There was a reduced time of onset and extended duration of anesthesia in the dorsal region

173

compared with the middle (p = 0.012 and p = 0.028, respectively) and ventral (p = 0.045 and

174

p = 0.048, respectively) regions in CON and a significantly greater duration of anesthesia in

175

the dorsal (p = 0.016) and middle (p = 0.008) regions compared with the ventral region in

176

ALC (Table 2). Onset of anesthesia was not different between these regions in ALC (Table

177

2). Times of onset and duration of anesthesia for all tested sites in both treatments are

178

presented in Table 3.

179

HR, fR and RT did not change between baseline and the subsequent times in both treatments.

180

There were no statistical differences in ataxia scores between treatments. Ataxia was first

181

detected at 15 minutes after epidural injection in both treatments. Duration of ataxia was

182

shorter in ALC (84.0 ± 29.2 minutes) than in CON ( 125.8 ± 51.0 minutes) (p = 0.033). Two

183

animals were assigned ataxia scores of 2 and one animal a score of 1 in both treatments. Two

184

more animals displayed ataxia in both treatments; one animal was scored 3 in CON and 2 in

185

ALC, and the other animal was scored 2 in CON and 1 in ALC. The sixth animal was scored

186

2 in CON but displayed no ataxia in ALC.

AC C

EP

TE D

M AN U

SC

RI PT

165

187 188

Discussion 8

ACCEPTED MANUSCRIPT The present study results show that alkalization of a commercial solution of lidocaine-

190

epinephrine to a physiological pH value results in a shorter time of onset of anesthesia close

191

to the anogenital area in epidural anesthesia in mares. The alkalization of local anesthetics

192

with sodium bicarbonate was first reported in 1901, resulting in increased potency and shorter

193

onset of action of procaine (Patel et al. 1996). Similarly, lidocaine combined with sodium

194

bicarbonate for pH adjustment resulted in faster onset of anesthesia and surgical anesthesia,

195

as well as faster spread of sensory blockade (DiFazio et al. 1986).

196

The addition of carbon dioxide (carbonization) to lidocaine has also been shown to hasten the

197

onset and improve epidural anesthesia in humans (Bromage 1965; Schelling & Klein 1985;

198

Garcia 2015). However, its epidural use in horses did not alter the time of onset, the duration,

199

or the extent of the block (Schelling & Klein 1985). A commercially available lidocaine-

200

epinephrine solution, which has a lower pH to avoid oxidation of epinephrine and increase

201

shelf life (Moore 1981; Lambert 2002; Garcia 2015), was used in our study. Thus, the marked

202

difference in the pH of tested solutions (2.98 to 7.44) in the present study when compared to

203

those from the study that used carbonization (5.3 to 6.5) may explain such discrepancies.

204

In comparison, epidural block with lidocaine in cattle may take less than 5 minutes to develop

205

complete perineal analgesia (Bigham et al. 2010), whereas the block may take up to 20

206

minutes to develop in horses (Hall et al. 2001). The longer time for developing epidural

207

anesthesia in horses after lidocaine epidural injection may induce the veterinarian to falsely

208

conclude that the epidural space was not reached (Hall et al. 2001). A reasonable explanation

209

for this difference was not found in the literature. However, this study showed that

210

alkalization of the anesthetic solution may provide more consistent epidural anesthesia in

211

horses.

AC C

EP

TE D

M AN U

SC

RI PT

189

9

ACCEPTED MANUSCRIPT In the present study, the treatments were applied at least 72 hours apart. Considering that the

213

total body clearance of intravenously infused lidocaine in horses is 29 mL kg-1 minute-1

214

(Garcia 2015), the horses in this experiment would have taken 16 to 21 hours to have blood

215

free of circulating lidocaine. In humans, the slow absorption half-life of lidocaine-

216

epinephrine solution is 6.6 hours; therefore, it takes approximately 24 hours for 20 mL to be

217

completely absorbed from the epidural space (Tucker & Mather 1979). Nevertheless, the

218

order of treatments was randomly selected for each mare to offset possible effects of one

219

treatment on the other.

220

In the comparisons among the dorsal, middle, and ventral thirds within each treatment, the

221

onset of anesthesia was longer in the middle and ventral thirds compared with the dorsal third

222

in the CON treatment. In the ALC treatment such differences were not significant. This may

223

be explained by the improved absorption of anesthetic solutions with a physiological pH.

224

This homogeneity in the onset of action observed in the dorsal, middle and ventral thirds may

225

be considered another advantage of anesthetic solution pH adjustment for epidural

226

administration in mares. The duration of anesthesia, however, differed to a greater extent

227

between regions in the ALC than CON treatment. Further study is needed to determine the

228

mechanisms responsible for the greater heterogeneity of block duration with the ALC

229

solution.

230

Although individual asymmetries were observed in most animals, there were no significant

231

differences in the time of onset or duration of anesthetic action between the right and left

232

antimeres in either of the treatments. A finding of predominant asymmetry, consistent

233

desensitization of one antimere more than the other, could have indicated incorrect technique,

234

eg. angling the needle during insertion. Previous studies have reported that individual

235

variation in desensitized areas and asymmetries are common findings for epidural anesthesia

AC C

EP

TE D

M AN U

SC

RI PT

212

10

ACCEPTED MANUSCRIPT in horses (Skarda & Muir 1983; Schelling & Klein 1985). The presence of congenital

237

membranes or adhesions in the epidural space could explain the unilateral anesthesia

238

(Robinson & Natalini 2002), but no further investigation was made in these mares. To ensure

239

greater reliability in the comparison between treatments in this study, only mares with

240

symmetric and predictable responses in the pre-study testing were included in the

241

experimental protocol.

242

It has been proposed that increasing the volume or concentration of local anesthetic will

243

speed the onset of epidural anesthesia and the addition of sodium bicarbonate may be of little

244

value (Lambert 2002). However, the pH of commercially available lidocaine solutions vary

245

and the lidocaine-epinephrine solution used in this study has a low pH. The results of this

246

study indicate that for this lidocaine preparation, correcting the acidity of the solution to a

247

physiologic pH is advantageous.

248

In the present study, no precipitation was observed in the anesthetic solution after bicarbonate

249

solution addition. However, precipitation after autoclaving has been reported in lidocaine

250

solutions with a pH above 7.4 (Zehetmayer et al. 1997; Fuchsjäger-Mayrl et al. 2002).

251

The specific gravity of solutions used in epidural anesthesia has been reported as an

252

influencing factor in time of onset. In addition, the density of a solution is not affected by the

253

concentration of anesthetic or volume administered. In their study of epidural anesthesia in

254

horses, DeRossi et al. (2005) attributed a more rapid onset with hyperbaric 5% lidocaine than

255

2% lidocaine to the difference in specific gravity. The densities of the solutions used in the

256

present study were similar, 1010 g L-1 and 1012 g L-1, and exceeded the density of equine

257

cerebrospinal fluid (1006 g L-1) (Polydoro et al. 2008). Therefore, the specific gravity of the

258

ALC and CON solutions was not considered an influencing factor in the reduced time of

259

onset in the ALC treatment.

AC C

EP

TE D

M AN U

SC

RI PT

236

11

ACCEPTED MANUSCRIPT Epinephrine, used as an additive for many local anesthetics, could potentially cause

261

cardiovascular effects when absorbed systemically, such as increased HR (Kozody et al.

262

1984; Garcia 2015) and decreased peripheral resistance (Niwa et al. 1991). In this study, HR

263

fluctuations remained within physiologic limits for the species and no adverse reactions,

264

other than ataxia, were induced by the anesthetic solutions.

265

The occurrence of ataxia is relatively common during epidural anesthesia in horses because

266

of the development of motor block (Hall et al. 2001; Robinson & Natalini 2002; Skarda et al.

267

2005; Carpenter & Byron 2015). In the present study, the animals showed a significantly

268

shorter duration of ataxia with the ALC than CON treatment. This may be interpreted as

269

differential block between motor and sensory fibers, because the duration of anesthesia did

270

not differ between treatments. A similar phenomenon was observed by Sadegh & Shafiei

271

(2008), who reported no ataxia in horses undergoing epidural block with lidocaine combined

272

with magnesium sulfate. Differences in ataxia among studies may be related to the different

273

additives, as there was no difference in anesthetic concentration between treatments in the

274

present study to explain the phenomenon. Medical reports have shown conflicting results

275

about the motor effects of adding sodium bicarbonate to lidocaine-epinephrine solution in

276

epidural anesthesia. Fukuda & Naito (1994) found no statistical difference in the intensity of

277

motor block, while Arakawa et al. (2002) and Curatolo et al. (1998) reported increased motor

278

block with an alkalinized solution.

279

The limited number of horses, the use of a standard volume of anesthetic for all mares, and

280

the lack of additional tests to differentiate sensory and motor block were considered

281

limitations of the present study. It is possible that the ALC solution may have yielded

282

statistical differences in the duration and extent of anesthesia if a larger number of horses had

283

been used.

AC C

EP

TE D

M AN U

SC

RI PT

260

12

ACCEPTED MANUSCRIPT 284

Conclusion

286

Epidural anesthesia was compared in six mares administered either lidocaine-epinephrine

287

(lidocaine 0.35 mg kg-1, epinephrine 1:200,000, pH 2.98) or lidocaine-epinephrine-sodium

288

bicarbonate (pH 7.44) by caudal epidural injection. The solution treated with sodium

289

bicarbonate resulted in reduction in the duration of ataxia and onset time of anesthesia in

290

areas adjacent to the anogenital region (within a radius of 10 cm), without reducing the

291

duration of epidural anesthesia. In addition, there was greater uniformity in the onset time of

292

anesthesia among the studied areas. The findings suggest that pH adjustment of lidocaine-

293

epinephrine solution prior to epidural injection may be advantageous for clinical use in

294

mares. Further elucidation about differential block, dose, duration, and spread of block with

295

alkalinized local anesthetics is necessary.

M AN U

SC

RI PT

285

296

Acknowledgments

298

The authors thank Dr. Rodrigo Valadares for background research and the insight about pH

299

buffering, and CNPq (Research Productivity), CAPES (MSscholarship), FAPEMIG

300

(Pesquisador Mineiro), and Pro Reitoria de Pesquisa UFMG for funding the research.

301

Authors declare no conflict of interest.

EP

AC C

302

TE D

297

303

Authors’ contributions

304

PCD: conduction of the experiment, data analysis, manuscript preparation. CFRP, APLO:

305

data collection and analysis. TPM, LOC: data collection, tabulation of data, animal handling.

306

RRF: study design, statistical analysis, manuscript preparation.

307

13

ACCEPTED MANUSCRIPT References

309

Arakawa M, Aoyama Y, Ohe Y (2002) Epidural bolus injection with alkalinized lidocaine

310

improves blockade of the first sacral segment–a brief report. Can J Anaesth 49, 566-570.

311

Bigham AS, Habibian S, Ghasemian F, Layeghi S (2010) Caudal epidural injection of

312

lidocaine, tramadol, and lidocaine–tramadol for epidural anesthesia in cattle. J Vet Pharmacol

313

Ther 33, 439–443.

314

Bromage, PR (1965) A comparison of the hydrochloride and carbon dioxide salts of lidocaine

315

and prilocaine in epidural analgesia. Acta Anaesthesiol Scand 16, 55-69.

316

Carpenter RE, Byron CR (2015) Equine local anesthetic and analgesic techniques. In: Lumb

317

& Jones Veterinary Anesthesia and Analgesia (5th edn). Grimm KA, Lamont LA, Tranquilli

318

WJ et al. (eds). John Wiley & Sons, USA. pp. 886–911.

319

Curatolo M, Petersen-Felix S, Arendt-Nielsen L et al. (1998) Adding sodium bicarbonate to

320

lidocaine enhances the depth of epidural blockade. Anesth Analg, 86, 341-347.

321

DeRossi R, Frazílio FO, Kassab TA (2005) Comparison of 2% lidocaine and hyperbaric 5%

322

lidocaine for caudal epidural analgesia in horses. J Equine Vet Sci 25, 198–205.

323

DiFazio CA, Carron H, Grosslight KR et al. (1986) Comparison of pH-adjusted lidocaine

324

solutions for epidural anesthesia. Anesth Analg 65, 760–764.

325

Eccarius SG, Gordon ME, Parelman JJ (1990) Bicarbonate-buffered lidocaine–epinephirine–

326

hyaluronidase for eyelid anesthesia. Ophthalmology 97, 1499–1501.

327

Fernando R, Jones HM (1991) Comparison of plain and alkalinized local anaesthetic

328

mixtures of lignocaine and bupivacaine for elective extradural caesarean section. Br J

329

Anaesth 67, 699–703.

330

Fuchsjäger-Mayrl G, Zehetmayer M, Plass H, Turnheim K (2002) Alkalinization increases

331

penetration of lidocaine across the human cornea. J Cataract Refract Surg 28, 692–696.

AC C

EP

TE D

M AN U

SC

RI PT

308

14

ACCEPTED MANUSCRIPT Fukuda T, Naito H (1994) The effect of pH adjustment of 1% lidocaine on the onset of

333

sensory and motor blockade of epidural anesthesia in nonpregnant gynecological patients. J

334

Anesth 8, 293–296.

335

Garcia ER (2015) Local anesthetics. In: Lumb & Jones Veterinary Anesthesia and Analgesia

336

(5th edn). Grimm KA, Lamont LA, Tranquilli WJ et al. (eds). John Wiley & Sons, Iowa,

337

USA, pp. 332–354.

338

Hall LW, Clarke KW, Trim CM (2001) General principles of local analgesia: anaesthesia of

339

the horse. In: Veterinary Anaesthesia (10th edn). Hall LW, Clarke KW, Trim CM (eds). W.

340

B. Saunders, UK. pp. 224–313.

341

Kozody R, Palahniuk RJ, Wade JG et al. (1984) The effect of subarachnoid epinephrine and

342

phenylephrine on spinal cord blood flow. Can Anaesth Soc J 31, 503–508.

343

Lambert DH (2002) Clinical value of adding sodium bicarbonate to local anesthetics. Region

344

Anesth Pain Med 27, 328–329.

345

McKay W, Morris R, Mushlin P (1987) Sodium bicarbonate attenuates pain on skin

346

infiltration with lidocaine, with or without epinephrine. Anesth Analg 66, 572–574.

347

Moore DC (1981) The pH of local anesthetic solutions. Anesth Analg 60, 833-834.

348

Moyer W, Schumacher J, Schumacher J (2011) Epidural Anesthesia. In: Equine Joint

349

Injection and Regional Anesthesia (2nd edn). Moyer W, Schumacher J, Schumacher J (eds).

350

Academic Veterinary Solutions, USA. pp. 140–143.

351

Niwa H, Hirota Y, Sibutani T et al. (1991) The effects of epinephrine and norepinephrine

352

administered during local anesthesia on left ventricular diastolic function. Anesth Prog 38,

353

221–226.

AC C

EP

TE D

M AN U

SC

RI PT

332

15

ACCEPTED MANUSCRIPT Patel M, Craig R, Laishley R (1996) A comparison between epidural anaesthesia using

355

alkalinized solution and spinal (combined spinal/epidural) anaesthesia for elective caesarean

356

section. Int J Obstet Anesth 5, 236–239.

357

Polydoro AS, Raiser AG, Natalini CC et al. (2008) Making of an in vitro experimental model

358

of equine subarachnoid space to test hyperbaric opioids. Cienc Rural 38, 384–388.

359

Robinson EP, Natalini CC (2002) Epidural anesthesia and analgesia in horses. Vet Clin North

360

Am Equine Pract 18, 61–82.

361

Sadegh AB, Shafiei Z (2008) Comparison of caudal epidural anesthesia with lidocaine–

362

distilled water and lidocaine–MgSO4 mixture in horses. J Equine Vet Sci 28, 341–344.

363

Schelling CG, Klein LV (1985) Comparison of carbonated lidocaine and lidocaine

364

hydrochloride for caudal epidural anesthesia in horses. Am J Vet Res 46, 1375–1377.

365

Skarda RT, Muir WW (1983) Continuous caudal epidural and subarachnoid anesthesia in

366

mares: a comparative study. Am J Vet Res 44, 2290–2298.

367

Skarda RT, Grosenbaugh DA, Muir WW (2005) Caudal regional anaesthesia in

368

horses. Equine Vet Educ 15, 108–116.

369

Taylor P, Coumbe K, Henson F et al. (2014) Evaluation of sedation for standing clinical

370

procedures in horses using detomidine combined with buprenorphine. Vet Anaesth Analg 41,

371

14–24.

372

Tucker GT, Mather LE (1979) Clinical pharmacokinetics of local anaesthetics. Clin

373

Pharmacokinet 4, 241–278.

374

Zehetmayer M, Rainer G, Turnheim K et al. (1997) Topical anesthesia with pH-adjusted

375

versus standard lidocaine 4% for clear corneal cataract surgery. J Cataract Refract Surg 23,

376

1390–1393.

AC C

EP

TE D

M AN U

SC

RI PT

354

377 378 16

ACCEPTED MANUSCRIPT 379

Table 1 Onset time and duration of epidural anesthesia in the sacral, anogenital, and

380

perianogenital regions in six mares treated with 10 mL of lidocaine-epinephrine solution with

381

(ALC, pH 7.4) or without (CON, pH 2.9) alkalization. Onset (minutes)

Duration (minutes)

ALC

p-value

CON

SC

12.5 ± 2.7

7.5 ± 2.9

0.029

113.9 ± 57.0

AG

19.1 ± 7.9

16.5 ± 13.2

0.496

101.2 ± 62.0

P5

20.2 ± 9.4

13.0 ± 8.2

0.003

102.2 ± 64.6

P10

18.6 ± 6.4

12.6 ± 6.2

0.005

P15

23.9 ± 10.2

18.5 ± 12.6

P20

24.4 ± 13.3

30.2 ± 26.3

p-value

110 ± 53.2

0.905

94.8 ± 44.3

0.770

103.3 ± 43.5

0.960

103.5 ± 63.3

106.5 ± 39.9

0.902

0.283

87.6 ± 57.1

71.4 ± 39.4

0.466

0.779

63.9 ± 57.5

48.7 ± 52.0

0.431

M AN U

382

ALC

SC

CON

RI PT

Region

Values are shown as means ± standard deviation.

384

SC, sacral region; AG, anogenital region; P5-P20, perianogenital region 5, 10, 15, or 20 cm

385

outside the anogenital region; CON, control treatment; ALC, alkalinized treatment.

386

p-values < 0.05 indicate significant difference between treatments for that region.

389 390 391

EP

388

AC C

387

TE D

383

392

17

ACCEPTED MANUSCRIPT 393

Table 2 Onset time and duration of epidural anesthesia in the dorsal, middle, and ventral

394

thirds of the perianogenital region in six mares treated with 10 mL of lidocaine-epinephrine

395

solution with (ALC, pH 7.4) or without (CON, pH 2.9) alkalization. Onset (minutes) CON

ALC

Duration (minutes) CON

ALC

RI PT

Area

16.2 ± 2.4a

13.6 ± 9.1a

107.5 ± 51.8a

98.2 ± 3.0a

Middle

23.4 ± 4.2b

18.0 ± 9.2a

87.9 ± 51.6b

84.9 ± 9.7a

Ventral

28.1 ± 9.8b

21.9 ± 9.3a

72.5 ± 46.8b

62.9 ± 18.4b

396

SC

Dorsal

Data are means ± standard deviations.

398

Means with the same letter do not differ within each treatment (p < 0.05).

399

AC C

EP

TE D

400

M AN U

397

18

ACCEPTED MANUSCRIPT 401

Table 3 Onset time and duration of epidural anesthesia in perianogenital sites of six mares

402

treated with 10 mL of lidocaine-epinephrine solution with (ALC, pH 7.4) or without (CON,

403

pH 2.9) alkalization.

404

Onset (minutes)

Duration (minutes) CON

RI PT

Tested site

ALC

p-value

ALC

p-value

SCP10

10.8 ± 2.0

5.8 ± 2.0

0.011

121.7 ± 55.9 119.2 ± 50.9

0.935

SCP15

12.5 ± 4.2

8.3 ± 2.6

0.042

112.5 ± 54.9 109.2 ± 53.1

0.920

SCP20

14.2 ± 2.0

8.3 ± 4.1

0.034

107.5 ± 60.1 101.7 ± 55.6

0.868

Anus

15.0 ± 8.4

9.2 ± 4.9

0.058

117.5 ± 58.6 118.3 ± 36.6

0.966

Perineum

17.5 ± 6.1

12.5 ± 9.3

0.041

110.0 ± 62.0 102.5 ± 46.8

0.802

Dorsal VC

20.0 ± 7.7

19.2 ± 20.3

0.908

97.5 ± 59.8

93.3 ± 53.3

0.874

Ventral VC 24.0 ± 13.4 25.0 ± 20.0

1.000

80.0 ± 67.5

65.0 ± 40.7

0.480

P5TDe

13.3 ± 2.6

8.3 ± 4.1

0.012

129.2 ± 53.5 124.2 ± 47.8

0.842

P5TDd

15.8 ± 7.4

8.3 ± 4.1

0.007

116.7 ± 67.3 126.7 ± 50.4

0.721

P5TMe

16.0 ± 8.2

10.0 ± 4.5

0.206

104.2 ± 70.1 112.5 ± 42.0

0.725

P5TMd

26.0 ± 13.9 16.7 ± 10.8

0.071

90.8 ± 66.0

98.3 ± 41.8

0.772

P5TVe

25.0 ± 12.2

17.5 ± 9.9

0.030

87.5 ± 66.7

90.0 ± 30.5

0.900

P5TVd

25.0 ± 12.2 17.0 ± 15.6

0.512

85.0 ± 64.1

68.3 ± 48.6

0.550

P10TDe

15.0 ± 7.7

7.5 ± 2.7

0.060

120.0 ± 53.9 120.0 ± 47.7

1.000

P10TDd

12.5 ± 2.7

7.5 ± 2.7

0.041

110.0 ± 63.9 125.0 ± 42.1

0.615

P10TMe

15.0 ± 0.0

10.8 ± 3.8

0.042

107.5 ± 66.0 119.2 ± 45.9

0.574

P10TMd

19.1 ± 8.6

14.2 ± 8.6

0.111

98.3 ± 64.5

100.8 ± 37.1

0.927

P10TVe

27.5 ± 11.3 16.7 ± 10.8

0.016

92.5 ± 67.4

103.3 ± 35.4

0.640

M AN U

TE D

EP

AC C

SC

CON

19

ACCEPTED MANUSCRIPT 22.5 ± 8.2

19.2 ± 8.6

0.235

92.5 ± 63.9

70.8 ± 31.2

0.465

P15TDe

12.5 ± 2.7

8.3 ± 2.6

0.093

117.5 ± 49.1

94.2 ± 48.3

0.345

P15TDd

16.7 ± 6.8

17.5 ± 21.1

0.932

103.3 ± 63.5

77.5 ± 27.9

0.353

P15TMe

22.5 ± 8.2

12.5 ± 2.7

0.049

100.0 ± 59.0

90.0 ± 52.2

0.737

P15TMd

22.5 ± 8.2

18.3 ± 20.9

0.611

92.5 ± 59.6

66.7 ± 28.0

0.389

P15TVe

30.0 ± 15.0 22.0 ± 11.5

0.560

52.5 ± 60.6

66.7 ± 49.6

0.389

P15TVd

39.0 ± 20.1 32.5 ± 16.6

0.754

60.0 ± 51.1

33.3 ± 30.6

0.396

P20TDe

24.0 ± 8.2

31.2 ± 30.9

0.739

72.5 ± 54.8

64.2 ± 69.4

0.648

P20TDd

20.0 ± 9.3

31.0 ± 26.8

0.813

90.8 ± 64.1

54.2 ± 32.8

0.164

P20TMe

22.5 ± 8.7

38.7 ± 29.3

0.562

55.0 ± 57.4

51.7 ± 64.5

0.861

P20TMd

33.7 ± 22.5 31.2 ± 25.6

0.093

55.0 ± 50.8

39.2 ± 38.3

0.487

P20TVe

20.0 ± 8.7

17.5 ± 17.7

0.500

62.5 ± 69.3

49.2 ± 60.9

0.628

P20TVd

26.2 ± 22.5 31.7 ± 27.5

0.874

47.5 ± 48.8

34.2 ± 46.3

0.515

M AN U

SC

RI PT

P10TVd

TE D

405

Data are means ± standard deviations.

407

Each tested site is represented by letter and number combinations: SC, sacral region; P5-P20,

408

perianogenital region at 5, 10, 15, and 20 cm outside the anogenital region; TD, dorsal third;

409

TV, ventral third; TM, middle third; e, left; d, right; VC, vulvar commissure.

410

p-values < 0.05 indicate a significant difference between treatments for that region.

412

AC C

411

EP

406

20

ACCEPTED MANUSCRIPT Figure Legends

414

Figure 1 Delineation of areas around the anogenital region. (a) Four concentric ellipses were

415

drawn at 5 cm (P5), 10 cm (P10), 15 cm (P15) and 20 cm (P20) outside the virtual ellipse

416

delimiting the anus and vulva (anogenital; AG region). Two lines were drawn parallel to the

417

floor, the first level with the anal sphincter and the second level with the ventral vulvar

418

commissure, separating the test area into dorsal (TD), middle (TM) and ventral (TV) thirds.

419

Two lines were drawn parallel to the longitudinal axis of the sacral vertebrae at the level of

420

the lateral borders of the tail, delimited the sacral (SC) region. The white spots indicate the

421

test sites located at the centers of the areas delimited in both antimeres and the sacrum, and at

422

the anal sphincter, perineum, dorsal vulvar commissure, and ventral vulvar commissure. (b)

423

Testing areas were drawn on the horse before conducting the experiment.

M AN U

SC

RI PT

413

AC C

EP

TE D

424

21

AC C

EP

TE D

M AN U

SC

RI PT

ACCEPTED MANUSCRIPT